You are here

Catalyst Pharma

With a substantial discount to Catalyst's Firdapse, is Jacobus poised to win physician, payer support for off-label adult LEMS use?

With a substantial discount to Catalyst's Firdapse, is Jacobus poised to win physician, payer support for off-label adult LEMS use?

Endpoints

Jacobus Pharmaceuticals

Catalyst Pharma

Lambert-Eaton myasthenic syndrome

Flag link:

Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug

Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug

Pharmaforum

Catalyst Pharma

Flag link:

Catalyst defends $375,000 drug price after Bernie Sanders rebuke

Catalyst defends $375,000 drug price after Bernie Sanders rebuke

Reuters

Catalyst Pharma

Flag link:

Firdapse re-catalyzes pricing debate

Firdapse re-catalyzes pricing debate

BioCentury

Catalyst Pharma

Flag link:

Catalyst's Firdapse Receives FDA Approval for Rare Disease

Catalyst's Firdapse Receives FDA Approval for Rare Disease

Yahoo/Zacks.com

Catalyst Pharma

Flag link:

Catalyst shares jazzed by a new round of positive results for a rare neuromuscular disease

Catalyst shares jazzed by a new round of positive results for a rare neuromuscular disease

Endpoints

Catalyst Pharma

Lambert-Eaton myasthenic syndrome

Flag link: